Assessing Bladder Cancer Risk in Type 2 Diabetes Clinical Trials: the Dapagliflozin Drug Development Program as a ‘Case Study’

Assessing Bladder Cancer Risk in Type 2 Diabetes Clinical Trials: the Dapagliflozin Drug Development Program as a ‘Case Study’

Bibliographic Details
Main Authors: Ptaszynska, Agata, Cohen, Samuel M., Messing, Edward M., Reilly, Timothy P., Johnsson, Eva, Johnsson, Kristina
Format: Online
Language:English
Published: Springer Healthcare 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4575305/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4575305/

Similar Items